ici 164384 has been researched along with enclomiphene in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gottardis, MM; Jordan, VC; Satyaswaroop, PG | 1 |
Musgrove, EA; Sutherland, RL; Wakeling, AE | 1 |
Giambiagi, N; Pasqualini, JR; Sumida, C | 1 |
Collins, DC; Gagliardi, A | 1 |
1 review(s) available for ici 164384 and enclomiphene
Article | Year |
---|---|
Pharmacodynamic and biological effects of anti-estrogens in different models.
Topics: Animals; Antibodies, Monoclonal; Cell Division; Clomiphene; DNA-Binding Proteins; Estradiol; Estrogen Antagonists; Female; Growth Substances; Humans; Lipoproteins, LDL; Liver; Nafoxidine; Nitromifene; Polyunsaturated Alkamides; Pyrrolidines; Receptors, Estrogen; Receptors, Progesterone; Species Specificity; Structure-Activity Relationship; Tamoxifen; Thiophenes; Uterus | 1988 |
3 other study(ies) available for ici 164384 and enclomiphene
Article | Year |
---|---|
Tamoxifen-stimulated growth of human endometrial carcinoma.
Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Clomiphene; Enclomiphene; Endometrium; Estradiol; Estrogen Antagonists; Female; Humans; Mice; Mice, Inbred BALB C; Nafoxidine; Neoplasm Transplantation; Piperidines; Polyunsaturated Alkamides; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms | 1991 |
Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
Topics: Breast Neoplasms; Calmodulin; Cell Cycle; Clomiphene; DNA; Estradiol; Estrogen Antagonists; Female; Humans; Imidazoles; Polyunsaturated Alkamides; Tumor Cells, Cultured | 1989 |
Inhibition of angiogenesis by antiestrogens.
Topics: Animals; Chick Embryo; Clomiphene; Dimethyl Sulfoxide; Dimethylformamide; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Estrogen Antagonists; Fulvestrant; Heparin; Hydrocortisone; Nafoxidine; Neovascularization, Pathologic; Polyunsaturated Alkamides; Solubility; Tamoxifen | 1993 |